Differences and similarities between the symptoms and clinical signs in patients with pulmonary tuberculosis and pneumonia

sonja smiljic; Blagica  Radović; Aleksandra  Ilić; Goran  Trajković; Sladjana  Savić; Zvezdan  Milanović; Milica  Mijović

doi:10.2298/VSP170301080S

sonja smiljic Institut za fiziologiju, Medicinski fakultet Kosovska Mitrovica
Blagica Radović Health Centre, Department of Pulomonology, Kosovska Mitrovica, Serbia
Aleksandra Ilić University of Priština/Kosovska Mitrovica, Faculty of Medicine, Institute for Medical Statistics and Informatics, Serbia
Goran Trajković University of Belgrade, Faculty of Medicine, Institute for Medical Statistics and Informatics, Belgrade, Serbia
Sladjana Savić University of Priština/Kosovska Mitrovica, Faculty of Medicine, *Department of Physiology, Serbia
Zvezdan Milanović University of Priština/Kosovska Mitrovica, Faculty of Medicine, Department of Physiology, Serbia
Milica Mijović University of Priština/Kosovska Mitrovica, Faculty of Medicine, *Department of Physiology, Serbia

DOI: https://doi.org/10.2298/VSP170301080S

Keywords: tuberculosis, pulmonary, pneumonia, signs and symptoms, risk factors

Abstract

Abstract

Background/Aim. Tuberculosis in the second decade of the 21st century is an infectious disease with the highest mortality rate. In addition, in developed countries, pneumonia is the major couse of morbidity and mortality in adults. The aim of our study was to point out the differences and similarities between symptoms, laboratory parameters and clinical indicators in patients with pulmonary tuberculosis (PTB) and patients with pneumonia in the general population and in people belonging to the high risk groups for developing tuberculosis. Methods. This prospective study included patients with PTB (n = 70) and pneumonia (n = 75) treated at the Pulmonology Department of Clinical Hospital Center in Kosovska Mitrovica. Results. PTB was more frequent in men, 30–39 years of age (OR; 6:08), mainly from rural areas (p = 0.001), and with lower levels of education (p = 0.031). Pneumonia was more frequent in women older than 60 years of age (p = 0.0012). Night sweats (p = 0.001) and weight loss (p = 0.062) were significantly more frequent in patients with PTB, while chest pain (p = 0.001) and high temperature (p = 0.036) were more common in patients with pneumonia. X-ray changes in patients with PTB were located in the upper fields (p = 0.001), or appeared to be bilateral (p = 0.004). The strongest predictor associated with an increased risk of night sweats was diagnosed PTB (OR = 30.0). The chest pain was a predictor of pneumonia, unilateral changes (OR = 4.65) in the lower lung fields (OR = 0.08). Conclusion. Night sweats, weight loss and chest X-ray abnormalities in upper fields were significant indicators of PTB. Chest pain, fever and chest X-ray abnormalities in lower fields were significant indicators of pneumonia.

Author Biography

sonja smiljic, Institut za fiziologiju, Medicinski fakultet Kosovska Mitrovica

Srbija

References

REFERENCES

World Health Organization. Global tuberculosis report. Ge¬neva: World Health Organization; 2016.

Yanai JN. The role of qualitative research in ending TB. Pub Health Action 2016; 6(4): 209.

Van't Hoog AH, Onozaki I, Lonnroth K. Choosing algo¬rithms for TB screening: a modelling study to compare yield, predictive value and diagnostic burden. BMC Infect Dis 2014; 14: 532.

Aguiar FS, Torres RC, Pinto JV, Kritski AL, Seixas JM, Mello FC. Development of two artificial neural network models to support the diagnosis of pulmonary tuberculosis in hospitalized patients in Rio de Janeiro. Brazil. Med Biol Eng Comput 2016; 54(11): 1751–9.

Colebunders R, Bastian I. A review of the diagnosis and treat-ment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 2000; 4(2): 97–107.

Kapoor AK, Deepani V, Dhall M, Kapoor S. Pattern of socio-economic and health aspects among TB patients and con¬trols. Indian J Tuberc 2016; 63(4): 230–5.

Proaño A, Bravard MA, Tracey BH, López JW, Comina G, Zimic M, et al. Protocol for studying cough frequency in people with pulmonary tuberculosis. BMJ Open 2016; 6(4): e010365.

Patra J, Jha P, Rehm J, Suraweera W. Tobacco smoking, alco¬hol drinking, diabetes, low body mass index and the risk of self-reported symptoms of active tuberculosis: indi¬vidual partici-pant data (IPD) meta-analyses of 72,684 indi¬viduals in 14 high tuberculosis burden countries. PLoS One 2014; 9(5): e96433.

Van't Hoog AH, Meme HK, Laserson KF, Agaya JA, Muchiri BG, Githui WA, et al. Screening strategies for tuberculosis preva-lence surveys: The value of chest radiography and symptoms. PLoS One 2012; 7(7): e38691.

Geyser M, Smith S. Chest pain prevalence, causes, and disposi-tion in the emergency department of a regional hospital in Pretoria. Afr J Prim Health Care Fam Med 2016; 8(1): e1–5.

Yaranal PJ, Umashankar T, Harish SG. Hematological Pro¬file in Pulmonary Tuberculosis. Int J Health Rehabil Sci 2013; 2(1): 50–5.

Babamahmoodi F, Alikhani A, Yazdani Charati J, Ghovvati A, Ahangarkani F, Delavarian L, et al. Clinical epidemiol¬ogy and paraclinical findings in tuberculosis patients in north of Iran. Biomed Res Int 2015; 2015: 381572.

Churchyard GJ, Fielding KL, Lewis JJ, Chihota VN, Hanifa Y, Grant AD. Symptom and chest radiographic screening for in-fectious tuberculosis prior to starting isoniazid pre¬ventive therapy: yield and proportion missed at screening. AIDS 2010; 24 Suppl 5: S19–27.

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Raga-Luria X,Gomez-Bertomeu F. EPIVAC Study Group. Epidemiology of community-acquired pneumonia in older adults: a population-based study. Respir Med 2009; 103(2): 309–16.

Torres A, Peetermans WE, Viegi G, Blasi F. Risk factors for community-acquired pneumonia in adults in Europe: A litera-ture review. Thorax 2013; 68(11): 1057–65.

Kabeya Y, Shimada A, Tsukada N, Atsumi Y, Higaki M. Dia-betes Affects Length of Stay and Hospital Costs for Eld¬erly Patients with Pneumonia: An Analysis of a Hospital Administrative Database. Tokai J Exp Clin Med 2016; 41(4): 203–9.

Rivero-Calle I, Pardo-Seco J, Aldaz P, Vargas DA, Mascarós E, Redondo E, et al. NEUMOEXPERTOS group. Inci¬dence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project). BMC Infect Dis 2016; 16(1): 645.

Feng Y, Kong Y, Barnes PF, Huang F, Klucar P, Wang X, et al. Exposure to cigarette smoke inhibits the pulmonary T-cell re-sponse to influenza virus and Mycobacterium tuber¬culosis. In-fect Immun 2011; 79(1): 229–37.

Przybylski G, Dąbrowska A, Trzcińska H. Alcoholism and other socio-demographic risk factors for adverse TB-drug reactions and unsuccessful tuberculosis treatment - data from ten years' observation at the Regional Centre of Pulmonology, Byd-goszcz, Poland. Med Sci Monit 2014; 20: 444–53.

Pednekar MS, Hakama M, Gupta PC. Tobacco use or body mass: Do they predict tuberculosis mortality in Mumbai, In-dia? Results from a population-based cohort study. PLoS ONE 2012; 7(7): e39443.

Magee MJ, Kempker RR, Kipiani M, Gandhi NR, Darchia L, Tuk-vadze N, et al. Diabetes mellitus is associated with cavi¬ties, smear grade, and multidrug-resistant tuberculosis in Georgia. Int J Tuberc Lung Dis 2015; 19(6): 685–92.

Gil-Santana L, Almeida-Junior JL, Oliveira CA, Hickson LS, Daltro C, Castro S,et al. Diabetes Is Associated with Worse Clinical Presentation in Tuberculosis Patients from Brazil: A Retrospective Cohort Study. PLoS One 2016; 11(1): e0146876.

Kirenga BJ, Ssengooba W, Muwonge C, Nakiyingi L, Kyali¬gonza S, Kasozi S, et al. Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control. BMC Public Health 2015; 15: 13.

Lönnroth K, Corbett E, Golub J, Godfrey-Faussett P, Uplekar M, Weil D, et al. Systematic screening for active tuberculo¬sis: Ra-tionale, definitions and key considerations. Int J Tuberc Lung Dis 2013; 17(3): 289–98.

Turner RD, Tweed CD, Shukla J, Bothamley GH. BCG and infection with Mycobacterium tuberculosis. Thorax 2015; 70(3): 286.

Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast ba¬cilli. Lancet 1999; 353(9151): 444–9.

Tostmann A, Kik SV, Kalisvaart NA, Sebek MM, Verver S, Boeree MJ, Soolingen D. Tuberculosis transmission by pa¬tients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis 2008; 47(9): 1135–42.

Cheng J, Wang L, Zhang H, Xia Y. Diagnostic value of symp-tom screening for pulmonary tuberculosis in China. PLoS One 2015; 10(5): e0127725.

Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Ta¬saneeyapan T, Kanara N, et al. An algorithm for tuberculo¬sis screening and diagnosis in people with HIV. N Engl J Med 2010; 362(8): 707–16.

Linguissi LS, Vouvoungui CJ, Poulain P, Essassa GB, Kwedi S, Ntoumi F. Diagnosis of smear-negative pulmonary tu¬berculosis based on clinical signs in the Republic of Congo. BMC Res Notes 2015; 8: 804.

Campos LC, Rocha MV, Willers DM, Silva DR. Characteris¬tics of Patients with Smear Negative Pulmonary Tubercu¬losis (TB) in a Region with High TB and HIV Prevalence. PLoS One 2016; 11(1): e01479933.

World Health Organization. Systematic Screening for Ac¬tive Tu-berculosis: Principles and Recommendations. Ge¬neva: World Health Organization; 2013.

Lee SW, Kang YA, Yoon YS, Um SW, Lee SM, Yoo CG, et al. The prevalence and evolution of anemia associated with tuberculosis. J Korean Med Sci 2006; 21(6): 1028–32.

Petrusevska-Marinkovic S, Kondova-Topuzovska I, Milenk¬ovic Z, Kondov G, Anastasovska A. Clinical, Laboratory and Radio-graphic Features of Patients with Pneumonia and Parapneu-monic Effusions. Open Access Maced J Med Sci 2016; 4(3): 428–34.